129 related articles for article (PubMed ID: 37477502)
1. miRNA 511_5p is a potential biomarker for ocular toxoplasmosis.
de Faria Júnior GM; Kumano LS; Bronchtein Gomes I; Camargos GS; Meira-Strejevitch CDS; Castiglioni L; Previato M; Pereira-Chioccola VL; Brandão CC; de Mattos LC
Trans R Soc Trop Med Hyg; 2023 Nov; 117(11):804-810. PubMed ID: 37477502
[TBL] [Abstract][Full Text] [Related]
2. Ocular toxoplasmosis associated with up-regulation of miR-155-5p/miR-29c-3p and down-regulation of miR-21-5p/miR-125b-5p.
Meira-Strejevitch CS; Pereira IS; Hippólito DDC; Maia MM; Cruz AB; Gava R; Brandão de Mattos CC; Frederico FB; Siqueira RC; Mattos LC; Pereira-Chioccola VL
Cytokine; 2020 Mar; 127():154990. PubMed ID: 31945658
[TBL] [Abstract][Full Text] [Related]
3. Biological Diagnosis of Ocular Toxoplasmosis: a Nine-Year Retrospective Observational Study.
Greigert V; Pfaff AW; Sauer A; Filisetti D; Candolfi E; Villard O
mSphere; 2019 Sep; 4(5):. PubMed ID: 31554726
[TBL] [Abstract][Full Text] [Related]
4. Specific IgM, IgG and IgG1 directed against Toxoplasma gondii detected by flow cytometry and their potential as serologic tools to support clinical indirect fundoscopic presumed diagnosis of ocular disease.
Martins LM; Rangel ALP; Peixe RG; Silva-Dos-Santos PP; Lemos EM; Martins-Filho OA; Bahia-Oliveira LMG
J Immunol Methods; 2015 Feb; 417():97-106. PubMed ID: 25527345
[TBL] [Abstract][Full Text] [Related]
5. CCR5 chemokine receptor gene polymorphisms in ocular toxoplasmosis.
de Faria Junior GM; Ayo CM; de Oliveira AP; Lopes AG; Frederico FB; Silveira-Carvalho AP; Previato M; Barbosa AP; Murata FHA; de Almeida Junior GC; Siqueira RC; de Mattos LC; Brandão de Mattos CC
Acta Trop; 2018 Feb; 178():276-280. PubMed ID: 29221851
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunological and molecular methods for laboratory diagnosis of ocular toxoplasmosis in blood, serum and tears in Brazil.
Ramos RCF; Barbosa ADS; Aleixo ALQDC; Arruda IF; Amendoeira MRR
PLoS One; 2024; 19(2):e0298393. PubMed ID: 38319921
[TBL] [Abstract][Full Text] [Related]
7. Immunological Molecular Responses of Human Retinal Pigment Epithelial Cells to Infection With
Lie S; Rochet E; Segerdell E; Ma Y; Ashander LM; Shadforth AMA; Blenkinsop TA; Michael MZ; Appukuttan B; Wilmot B; Smith JR
Front Immunol; 2019; 10():708. PubMed ID: 31118929
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of oxidative stress and antioxidative markers in patients infected with Toxoplasma gondii.
Paraboni MLR; Manfredini V; Schreiner GE; Gonçalves IL; Silveira C; Commodaro AG; Belfort R
Parasitol Int; 2022 Dec; 91():102645. PubMed ID: 35977613
[TBL] [Abstract][Full Text] [Related]
9. Plasma microRNAs are promising novel biomarkers for the early detection of Toxoplasma gondii infection.
Jia B; Chang Z; Wei X; Lu H; Yin J; Jiang N; Chen Q
Parasit Vectors; 2014 Sep; 7():433. PubMed ID: 25199527
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for ocular toxoplasmosis in Brazil.
Ferreira AI; De Mattos CC; Frederico FB; Meira CS; Almeida GC; Nakashima F; Bernardo CR; Pereira-Chioccola VL; De Mattos LC
Epidemiol Infect; 2014 Jan; 142(1):142-8. PubMed ID: 23507508
[TBL] [Abstract][Full Text] [Related]
11. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection.
Ongkosuwito JV; Bosch-Driessen EH; Kijlstra A; Rothova A
Am J Ophthalmol; 1999 Oct; 128(4):407-12. PubMed ID: 10577580
[TBL] [Abstract][Full Text] [Related]
12. Effects of sulfamethoxazole on murine ocular toxoplasmosis in interferon-gamma knockout mice.
Norose K; Aosai F; Mun HS; Yano A
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):265-71. PubMed ID: 16384972
[TBL] [Abstract][Full Text] [Related]
13. Plasma extracellular microRNAs are related to AIDS/cerebral toxoplasmosis co-infection.
Pereira IS; Maia MM; da Cruz AB; Telles JPM; Vidal JE; Gava R; Meira-Strejevitch CS; Pereira-Chioccola VL
Parasite Immunol; 2020 Apr; 42(4):e12696. PubMed ID: 31945196
[TBL] [Abstract][Full Text] [Related]
14. Duffy blood group system and ocular toxoplasmosis.
Ferreira AIC; Brandão de Mattos CC; Frederico FB; Bernardo CR; de Almeida Junior GC; Siqueira RC; Meira-Strejevitch CS; Pereira-Chioccola VL; de Mattos LC
Infect Genet Evol; 2020 Nov; 85():104430. PubMed ID: 32565360
[TBL] [Abstract][Full Text] [Related]
15. Utility of blood as the clinical specimen for the diagnosis of ocular toxoplasmosis using uracil DNA glycosylase-supplemented loop-mediated isothermal amplification and real-time polymerase chain reaction assays based on REP-529 sequence and B1 gene.
Rahimi Esboei B; Fallahi S; Zarei M; Kazemi B; Mohebali M; Shojaee S; Mousavi P; Teimouri A; Mahmoudzadeh R; Salabati M; Keshavarz Valian H
BMC Infect Dis; 2022 Jan; 22(1):89. PubMed ID: 35078413
[TBL] [Abstract][Full Text] [Related]
16. Intraocular anti-Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis.
Ronday MJ; Ongkosuwito JV; Rothova A; Kijlstra A
Am J Ophthalmol; 1999 Mar; 127(3):294-300. PubMed ID: 10088739
[TBL] [Abstract][Full Text] [Related]
17. Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis.
Bou G; Figueroa MS; Martí-Belda P; Navas E; Guerrero A
J Clin Microbiol; 1999 Nov; 37(11):3465-8. PubMed ID: 10523535
[TBL] [Abstract][Full Text] [Related]
18. Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels.
Meira CS; Pereira-Chioccola VL; Vidal JE; de Mattos CC; Motoie G; Costa-Silva TA; Gava R; Frederico FB; de Mattos LC;
Front Microbiol; 2014; 5():492. PubMed ID: 25352834
[TBL] [Abstract][Full Text] [Related]
19. Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with ocular toxoplasmosis: predominance of type II in France.
Fekkar A; Ajzenberg D; Bodaghi B; Touafek F; Le Hoang P; Delmas J; Robert PY; Dardé ML; Mazier D; Paris L
J Clin Microbiol; 2011 Apr; 49(4):1513-7. PubMed ID: 21248092
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of Positive Findings of
Park SW; Kim SH; Kwon HJ; Lee SM; Byon IS; Lee JE
Ocul Immunol Inflamm; 2019; 27(4):583-590. PubMed ID: 29513626
[No Abstract] [Full Text] [Related]
[Next] [New Search]
